Curcumin-loaded Nanostructured Lipid Carriers (NLCs) for Nasal Administration: Design, Characterization, and in Vivo Study

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2014 Nov 5

PMID 25367836

Citations 53

Authors

Rohini G Madane

Hitendra S Mahajan

Affiliations

Soon will be listed here.

Abstract

Cancer nanotherapeutics is beginning to overwhelm the global research and viewed to be the revolutionary treatment regime in the medical field. This investigation describes the development of a stable nanostructured lipid carrier (NLC) system as a carrier for curcumin (CRM). The CRM-loaded NLC developed as a particle with the size of 146.8 nm, a polydispersity index of 0.18, an entrapment efficiency (EE) of 90.86%, and the zeta potential (ZP) of -21.4 mV. Besides, the increased cytotoxicity of CRM-NLC than that of CRM to astrocytoma-glioblastoma cell line (U373MG) in the cancer cell lines was observed. Results of biodistribution studies showed higher drug concentration in brain after intranasal administration of NLCs than PDS. The results of the study also suggest that CRM-NLC is a promising drug delivery system for brain cancer therapy.

Citing Articles

Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations.

Shadab A, Farokhi S, Fakouri A, Mohagheghzadeh N, Noroozi A, Razavi Z Eur J Med Res. 2025; 30(1):71.

PMID: 39905470 PMC: 11792566. DOI: 10.1186/s40001-025-02310-2.

Exploring the anti-inflammatory activities, mechanism of action and prospective drug delivery systems of tocotrienol to target neurodegenerative diseases.

Mathew A, Bhuvanendran S, Nair R, Radhakrishnan A F1000Res. 2024; 12:338.

PMID: 39291146 PMC: 11406131. DOI: 10.12688/f1000research.131863.1.

Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)-Part II: Incorporation and Stability of Butamben with Different Surfactants.

Matarazzo A, Rios C, Geronimo G, Ondei R, de Paula E, Breitkreitz M Pharmaceutics. 2024; 16(7).

PMID: 39065560 PMC: 11280378. DOI: 10.3390/pharmaceutics16070863.

Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.

Agosti E, Zeppieri M, Antonietti S, Battaglia L, Ius T, Gagliano C Pharmaceutics. 2024; 16(3).

PMID: 38543223 PMC: 10975610. DOI: 10.3390/pharmaceutics16030329.

Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation.

Mainuddin , Kumar A, Ratnesh R, Singh J, Dumoga S, Sharma N Med Oncol. 2024; 41(5):95.

PMID: 38526657 DOI: 10.1007/s12032-024-02319-3.